Dr. Qiang Zhao 赵强
Chief Physician
Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of thoracic and abdominal tumors, especially esophageal cancer, lung cancer, mediastinal tumors, and gastric cancer.
Dr. Zhao graduated from Suzhou Medical College in 1995. As a medical team leader, Dr. Zhao has published multiple academic papers domestically and internationally. Since 2009, Dr. Zhao has performed minimally invasive surgery for lung cancer, esophageal cancer, and mediastinal tumors, with experience in thousands of minimally invasive and open procedures.
Professional roles
- Standing Committee Member, Esophageal Cancer Professional Committee, Zhejiang Anti-Cancer Association
Name order: in Chinese the family name comes first (Zhao Qiang). Papers usually list the name as Qiang Zhao or Zhao Q.
Selected publications
22 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Front Immunol, 2025 (first author): Pretreatment immune-inflammatory prognostic score in predicting clinical outcomes in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy. PubMed 40842988
- Sci Rep, 2024 (first author): Preoperative inflammatory burden index for prognostication in esophageal squamous cell carcinoma undergoing radical resection. PubMed 39730559
- Front Immunol, 2024 (first author): Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant immunochemotherapy. PubMed 39035002
- J Thorac Dis, 2024 (senior author): Molecular characteristics and multivariate survival analysis of 43 patients with locally advanced or metastatic esophageal squamous cell carcinoma. PubMed 38617776
- Bioengineered, 2021 (first author): LETM1 (leucine zipper-EF-hand-containing transmembrane protein 1) silence reduces the proliferation, invasion, migration and angiogenesis in esophageal squamous cell carcinoma via KIF14 (kinesin family member 14). PubMed 34605738
- J Thorac Cardiovasc Surg, 2018 (senior author): A prediction model for lymph node metastasis in T1 esophageal squamous cell carcinoma. PubMed 29233596
- Oncotarget, 2017 (first author): A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio. PubMed 29262582
- Ups J Med Sci, 2013 (senior author): Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor?. PubMed 23617771
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion